Selection of piperacillin/tazobactam infusion mode guided by SOFA score in cancer patients with hospital-acquired pneumonia: a randomized controlled study

Yang Lyu,1,* Yang Yang,2,* Xin Li,3 Min Peng,3 Xin He,2 Peng Zhang,4 Shangwen Dong,4 Wanhua Wang,2 Donghao Wang1 1Department of Intensive Care Unit, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therap...

Full description

Bibliographic Details
Main Authors: Lyu Y, Yang Y, Li X, Peng M, He X, Zhang P, Dong S, Wang W, Wang D
Format: Article
Language:English
Published: Dove Medical Press 2017-12-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Online Access:https://www.dovepress.com/selection-of-piperacillintazobactam-infusion-mode-guided-by-sofa-score-peer-reviewed-article-TCRM
id doaj-4796585051cb49fba09e4d3394044b7b
record_format Article
spelling doaj-4796585051cb49fba09e4d3394044b7b2020-11-24T23:46:30ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2017-12-01Volume 14313736107Selection of piperacillin/tazobactam infusion mode guided by SOFA score in cancer patients with hospital-acquired pneumonia: a randomized controlled studyLyu YYang YLi XPeng MHe XZhang PDong SWang WWang DYang Lyu,1,* Yang Yang,2,* Xin Li,3 Min Peng,3 Xin He,2 Peng Zhang,4 Shangwen Dong,4 Wanhua Wang,2 Donghao Wang1 1Department of Intensive Care Unit, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, 2Department of Anesthesia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, 3Department of Intensive Care Unit, Tianjin Medical University General Hospital, Tianjin, 4Department of Cardiothoracic Surgery, Tianjin Medical University General Hospital, Tianjin, China *These authors contributed equally to this work Background: This study aimed to select piperacillin/tazobactam (TZP) infusion mode guided by Sequential Organ Failure Assessment (SOFA) score in cancer patients with hospital-acquired pneumonia (HAP) postoperation.Patients and methods: A total of 120 cancer patients with postoperative HAP were divided into two groups: improved administration group (L group) and conventional treatment group (Con group). The Con group received traditional infusion of TZP and the L group received it as prolonged infusion. Blood drug concentration was detected at different time points. Based on the SOFA cut-off value of 9, the patients were regrouped into M (mild) and S (severe) groups.Results: Percent time that the free drug concentrations remain above the minimum inhibitory concentration (%fT>MIC) was longer than 5 h in L group, but <4 h in Con group. Administration method (p=0.033, OX value 2.796, B value 1.028, 95% CI: 0.855–8.934) and SOFA score (p=0.038, OX value 0.080, B value -2.522, 95% CI: 0.007–0.874) were independent predictors of patient survival. In the S group, compared to conventional treatment, prolonged infusion mode resulted in shorter days of antibiotic use and shorter ventilator time, and achieved longer survival, better clinical efficacy, and lower 28-day mortality rate.Conclusion: For cancer patients with SOFA score ≥9, prolonged infusion of TZP could benefit the patients and obtain better clinical efficacy. Keywords: cancer, Sequential Organ Failure Assessment score, piperacillin, tazobactam, pneumonia, antibiotics https://www.dovepress.com/selection-of-piperacillintazobactam-infusion-mode-guided-by-sofa-score-peer-reviewed-article-TCRMCancerSequential Organ Failure Assessment scorePiperacillinTazobactamPneumoniaAntibiotics
collection DOAJ
language English
format Article
sources DOAJ
author Lyu Y
Yang Y
Li X
Peng M
He X
Zhang P
Dong S
Wang W
Wang D
spellingShingle Lyu Y
Yang Y
Li X
Peng M
He X
Zhang P
Dong S
Wang W
Wang D
Selection of piperacillin/tazobactam infusion mode guided by SOFA score in cancer patients with hospital-acquired pneumonia: a randomized controlled study
Therapeutics and Clinical Risk Management
Cancer
Sequential Organ Failure Assessment score
Piperacillin
Tazobactam
Pneumonia
Antibiotics
author_facet Lyu Y
Yang Y
Li X
Peng M
He X
Zhang P
Dong S
Wang W
Wang D
author_sort Lyu Y
title Selection of piperacillin/tazobactam infusion mode guided by SOFA score in cancer patients with hospital-acquired pneumonia: a randomized controlled study
title_short Selection of piperacillin/tazobactam infusion mode guided by SOFA score in cancer patients with hospital-acquired pneumonia: a randomized controlled study
title_full Selection of piperacillin/tazobactam infusion mode guided by SOFA score in cancer patients with hospital-acquired pneumonia: a randomized controlled study
title_fullStr Selection of piperacillin/tazobactam infusion mode guided by SOFA score in cancer patients with hospital-acquired pneumonia: a randomized controlled study
title_full_unstemmed Selection of piperacillin/tazobactam infusion mode guided by SOFA score in cancer patients with hospital-acquired pneumonia: a randomized controlled study
title_sort selection of piperacillin/tazobactam infusion mode guided by sofa score in cancer patients with hospital-acquired pneumonia: a randomized controlled study
publisher Dove Medical Press
series Therapeutics and Clinical Risk Management
issn 1178-203X
publishDate 2017-12-01
description Yang Lyu,1,* Yang Yang,2,* Xin Li,3 Min Peng,3 Xin He,2 Peng Zhang,4 Shangwen Dong,4 Wanhua Wang,2 Donghao Wang1 1Department of Intensive Care Unit, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, 2Department of Anesthesia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin’s Clinical Research Center for Cancer, 3Department of Intensive Care Unit, Tianjin Medical University General Hospital, Tianjin, 4Department of Cardiothoracic Surgery, Tianjin Medical University General Hospital, Tianjin, China *These authors contributed equally to this work Background: This study aimed to select piperacillin/tazobactam (TZP) infusion mode guided by Sequential Organ Failure Assessment (SOFA) score in cancer patients with hospital-acquired pneumonia (HAP) postoperation.Patients and methods: A total of 120 cancer patients with postoperative HAP were divided into two groups: improved administration group (L group) and conventional treatment group (Con group). The Con group received traditional infusion of TZP and the L group received it as prolonged infusion. Blood drug concentration was detected at different time points. Based on the SOFA cut-off value of 9, the patients were regrouped into M (mild) and S (severe) groups.Results: Percent time that the free drug concentrations remain above the minimum inhibitory concentration (%fT>MIC) was longer than 5 h in L group, but <4 h in Con group. Administration method (p=0.033, OX value 2.796, B value 1.028, 95% CI: 0.855–8.934) and SOFA score (p=0.038, OX value 0.080, B value -2.522, 95% CI: 0.007–0.874) were independent predictors of patient survival. In the S group, compared to conventional treatment, prolonged infusion mode resulted in shorter days of antibiotic use and shorter ventilator time, and achieved longer survival, better clinical efficacy, and lower 28-day mortality rate.Conclusion: For cancer patients with SOFA score ≥9, prolonged infusion of TZP could benefit the patients and obtain better clinical efficacy. Keywords: cancer, Sequential Organ Failure Assessment score, piperacillin, tazobactam, pneumonia, antibiotics 
topic Cancer
Sequential Organ Failure Assessment score
Piperacillin
Tazobactam
Pneumonia
Antibiotics
url https://www.dovepress.com/selection-of-piperacillintazobactam-infusion-mode-guided-by-sofa-score-peer-reviewed-article-TCRM
work_keys_str_mv AT lyuy selectionofpiperacillintazobactaminfusionmodeguidedbysofascoreincancerpatientswithhospitalacquiredpneumoniaarandomizedcontrolledstudy
AT yangy selectionofpiperacillintazobactaminfusionmodeguidedbysofascoreincancerpatientswithhospitalacquiredpneumoniaarandomizedcontrolledstudy
AT lix selectionofpiperacillintazobactaminfusionmodeguidedbysofascoreincancerpatientswithhospitalacquiredpneumoniaarandomizedcontrolledstudy
AT pengm selectionofpiperacillintazobactaminfusionmodeguidedbysofascoreincancerpatientswithhospitalacquiredpneumoniaarandomizedcontrolledstudy
AT hex selectionofpiperacillintazobactaminfusionmodeguidedbysofascoreincancerpatientswithhospitalacquiredpneumoniaarandomizedcontrolledstudy
AT zhangp selectionofpiperacillintazobactaminfusionmodeguidedbysofascoreincancerpatientswithhospitalacquiredpneumoniaarandomizedcontrolledstudy
AT dongs selectionofpiperacillintazobactaminfusionmodeguidedbysofascoreincancerpatientswithhospitalacquiredpneumoniaarandomizedcontrolledstudy
AT wangw selectionofpiperacillintazobactaminfusionmodeguidedbysofascoreincancerpatientswithhospitalacquiredpneumoniaarandomizedcontrolledstudy
AT wangd selectionofpiperacillintazobactaminfusionmodeguidedbysofascoreincancerpatientswithhospitalacquiredpneumoniaarandomizedcontrolledstudy
_version_ 1716274880880574464